2017 PPAG Call for Abstracts

Annual Meeting Poster Abstract Submission Rules and Format Guidelines

ABSTRACT SUBMISSION DEADLINE: MARCH 1, 2017
SUBMISSION SITE: CLICK HERE

Introduction

Poster Presentations are informal discussions of current projects in pharmacy practice with meeting attendees. It is your opportunity share successful programs that have worked in pediatric healthcare systems, and to pick up ideas from others. This document will assist you in preparing your abstract for submission. Thank you for your interest in presenting at the 2017 PPAG Annual Meeting.

There are now 6 categories for submission

  1. Research/Scientific Abstracts
  2. Innovative/Novel Case Reports or Series (NEW)
  3. Best/Innovative Practice Abstracts
  4. Scholarship of Teaching Abstracts
  5. Residency Project Presentations
  6. Student Project Abstracts

 

All practitioners, investigators, post-doctoral trainees, and students in the field of pediatric clinical pharmacy, whether members of PPAG or not, are invited to submit abstracts of papers to be considered for platform or poster presentation at the 26th Annual PPAG Meeting and 2017 Pediatric Pharmacy Conference. The conference will be held at the Charlotte Marriott City Center in Charlotte, North Carolina. Poster and Platform Presentations will be held on Friday, May 5, 2017. Residency Research Project Presentations will be held on Thursday, May 4, 2017 and Saturday, May 6, 2017.

General Guidelines

Submission Deadline:

March 1, 2017 at 11:59 PM (Pacific) – Abstracts must be completed and submitted by this date; no new submissions or edits will be accepted after this deadline. PPAG will not edit abstracts. Incomplete abstracts will be deleted from the system after this deadline.

Submission Site: http://ppag.conference-services.net/authorlogin.asp?conferenceID=5286&language=en-uk

Primary Author: The person entering the information online is the primary author and is responsible for providing the required information to other authors. We define the “Primary Author” as the leading author and the primary presenter. The submitting author’s name will automatically appear first on the citation and the abstract, and their contact information will be printed on the published version of the abstract. Duplicate abstracts on the same topic from one author or institution will not be accepted. Your poster presentation at the PPAG Annual Meeting may not differ from the original accepted title and abstract content in your submission. It is understood that an author of the abstract will be at the meeting to present the poster.

Additional Authors: Each submission may have up to six (6) authors – the Primary Author and 5 additional authors. The primary author is responsible to ensure that all authors are included and in the order they will appear on the abstract and citation. PPAG will not add “forgotten” authors or make changes to the order of the authors.

Meeting Registration and Cancellations

Meeting Registration

Presenting a poster at our meeting is a voluntary effort and PPAG cannot pay expenses for your participation. If your submission is accepted, you are responsible for your own meeting registration fee and travel. Your meeting registration will confirm your participation in the Poster Session. All presenters must be registered for the meeting.

Withdrawals/Cancellations

Written notification is required for all submission withdrawals, and must be submitted by the primary author. Please send your withdrawal request by to: matthew.helms@ppag.org and include your full name, abstract number, and presentation title in the request. If you withdraw after receiving your acceptance notice, your presentation abstract will not appear in print, on the PPAG website or other media.

Prior Publication or Presentation

Previously presented or published abstracts (encore presentations) may be submitted for presentation at the PPAG Annual Meeting, but they will NOT be published in the Journal of Pediatric Pharmacology and Therapeutics (JPPT). Encore presentations will not be considered for an Award.  

Publication Rights

PPAG does not retain the exclusive rights of publication to poster abstracts submitted for our meeting.

  1. All research and practice abstracts should be no longer than 450 words.
  2. Research and practice abstracts will be published in the Journal of Pediatric Pharmacology and Therapeutics.
  3. Platform Presentations and Best Practice Awards will be chosen from the abstracts submitted.
  4. All Abstracts (except student & resident abstracts submitted in those categories) are required to have results and a conclusion to be considered for acceptance. Note: residents and students can submit abstracts in other categories, but results ARE required.

 

Notifications and Contact Information Email Notifications

All correspondences including confirmations, reminders, and accept/reject notifications will be sent to the primary author’s email only. It is the primary author’s responsibility to notify the co-authors of the status of the submission, and highly recommended that this email be a working address that is not spam protected.

Completing Your Abstract Submission

Abstract Title

  1. Title must accurately and concisely reflect the abstract content.
  2. Submission with titles that are NOT in the correct format will not be accepted.
  3. Only enter the title of the abstract in the title field. DO NOT put it in the abstract content field.


Title Format

  1. Do NOT use brand names of medications in the title
  2. Capitalize only the first letter of the first word in the title, all other words must be in lowercase letters; except in the case of acronyms or proper nouns.
  3. Do not use “An,” A,” or “The” as the first word in the title
  4. Spell out all pharmaceutical acronyms
  5. Special symbols (Mathematical signs – equals, plus, minus, percentage, greater than, less than etc.) must be spelled out.


Body of Abstract

  1. Your abstract will be reviewed and evaluated based on the content provided according to these guidelines.
  2. Word limits – the entire abstract should be no longer than 450 words.
  3. Proofread content carefully, particularly doses, drug names and numerical values.
  4. Use standard abbreviations. Do not include graphs, tables or illustration in your abstract.
  5. Do not use special functions such as tabs, underlines, trademarks, superscript, subscript, bold or italics. Special symbols such as Greek letters, degrees, plus signs, minus signs or greater than or less than signs must be spelled out.
  6. Do not include the title or authors in the body of the abstract.


Submission Type

Your abstract must match one of the following submission types:

  1. Research/Scientific Abstracts
  2. Innovative/Novel Case Reports or Series (NEW)
  3. Best/Innovative Practice Abstracts
  4. Scholarship of Teaching Abstracts
  5. Residency Project Presentations
  6. Student Project Abstracts

Research Scientific Abstracts (Results required for all authors)

Research abstracts presented at PPAG report the results of a scientific investigation or a clinical observation involving some aspect of pharmacotherapy. Scientific investigations can be either clinical, basic, or translational and are either hypothesis-driven or descriptive in nature. To be accepted for presentation, research abstracts must have final results. Abstracts without results will not be accepted in this category. Abstracts submitted under the Residency Project Presentations category cannot be submitted under this category.

All submissions will be eligible for the Young Investigator or Best Original Paper awards. The finalists will be judged by a panel of judges during the poster and platform presentation sessions. Primary authors may be considered for all awards for which they are eligible, but may win only one award.

Outstanding Original Paper:
Outstanding Original Paper Investigators will be evaluated on the basis of their written abstract and the quality of their presentation at the Meeting. The winner will receive complimentary registration to next year's Annual Meeting and a framed certificate.

Christensen Memorial Young Investigator Award:
PPAG Young Investigator Award is available to investigators who have been in practice five (5) years or less. This award will be granted to the investigator based on their written abstract and the quality of their presentation at the Meeting.

When submitting your abstract, please use the following section headings:

  1. Objectives
  2. ​Methods
  3. ​Results
  4. ​Conclusion
     

Abstracts will be reviewed based on the following criteria:

  1. The abstract is significant to pediatric pharmacy practice including applicability to other institutions or patients.
  2. The objective(s) of the research are clearly stated.
  3. The methods/procedures are appropriate and clearly described.
  4. The results are clearly and concisely presented with appropriate statistical analysis.
  5. The conclusions draw logically from the methods and results.

Innovative/Novel Case Reports or Series Presentation Abstracts (Final Report required for ALL authors)

This year, PPAG will be launching a separate Case Report/Case Studies Presentation. Current practitioners may submit their clinical observations within this category. Reports or projects are not limited to a specific research or project area, but should involve some aspect of pharmacotherapy and be descriptive in nature. To be accepted for presentation, the abstract must have a final report. Case Reports will NOT be published in the Journal of Pediatric Pharmacology and Therapeutics

When submitting your abstract, please use the following section headings:

  1. Introduction
  2. Case Report
  3. ​Conclusions

 

Abstracts will be reviewed for the following criteria:

  1. The abstract is significant to pediatric pharmacy practice, including applicability to other institutions or patients
  2. The abstract must contain rationale detailed description of the case.
  3. Case Studies must contain the headings: Introduction, Case Report, Conclusions.
  4. The work described must be complete.
  5. The statement “details/results will be discussed” will not be accessed.

Best Practice (Innovation in Practice) Abstracts (Results/Outcomes REQUIRED for ALL authors)

Best and Innovative Pediatric Pharmacy Practice Abstracts typically describe programs, systems, or projects that are creative, cost-effective, and improve practice in pediatric pharmacy. Abstracts will be reviewed based on the following criteria:

  1. Project presented is innovative/creative and supports the advancement of pediatric pharmacy practice
  2. Project presented demonstrates measurable outcomes/benefits (e.g., improved compliance, cost-effectiveness, decreased mortality)
  3. Project presented can be replicated at other institutions
  4. Abstract is clearly and concisely written


When submitting your abstract, please use the following section headings:

  1. Introduction
  2. ​Methods
  3. Results
  4. ​Conclusion

 

BPA Posters will be selected based on achievement of excellence in each of the four areas. Winners of the Best Practice Award will be chosen from accepted abstracts. The program, system, or project can be an individual or collaborative effort in any type of practice setting, including academia, institutional, or ambulatory care.

Chiesi Best Practice Awards
PPAG will award up to two (2) Best Practice Awards during the 26th Annual Meeting in Charlotte, NC. The awards are given to innovative and creative pharmacy programs that advance the mission, vision, and goals of the organization. Recipients of the award receive a certificate recognizing each contributor to the program. Award recipients will share their best practice during a presentation at the Annual Meeting and as a poster at the Annual Meeting. The Best Practice Awards are generously supported by Chiesi.

Best Practice Abstracts should include sufficient details about the rationale, process, and hypothesis of the impact should the program, system, or project be implemented. Accepted abstracts will be published in the Journal of Pediatric Pharmacology and Therapeutics. Submissions should include any pictures, graphs, figures and data tables that supports the summary. Each of these must be clearly labeled and described.


Scholarship of Teaching Abstracts (Results/Outcomes REQUIRED by all Authors)

PPAG will award up to two (2) Scholarship of Teaching Awards during the 24th Annual Meeting in Charlotte, NC. The awards are given to innovative and creative educational programs that advance the mission, vision, and goals of the organization. Recipients of the award receive a certificate recognizing each contributor to the program. Award recipients will share their teaching program as a poster at the Annual Meeting. Scholarship of Teaching Abstracts describe innovative educational programs that improve pediatric pharmacy practice. Abstracts may highlight educational programs with different audiences (i.e. PharmD students, residents, patients, caregivers, pharmacists). Abstracts will be reviewed based on the following criteria:

  1. Project presented is innovative/creative and supports the advancement of pediatric pharmacy practice
  2. Project presented demonstrates measurable outcomes/benefits (e.g., improved compliance, improved educational outcomes, increases in satisfaction scores)
  3. Project presented can be replicated at other institutions
  4. Project presented offers improvements in knowledge, skills, and/or attitudes of the intended audience (e.g., patients, care givers, students, residents, pharmacists)
  5. Abstract is clearly and concisely written

 

​When submitting your abstract, please use the following section headings:

  1. ​Intoduction
  2. Methods
  3. Results
  4. ​Conclusion

Student Project Abstracts (Results are not required)

In 2014, PPAG launched a Student Poster Presentation and created the Student Investigator Award. Primary investigators who are currently enrolled in a BSPharm or PharmD program can submit their project within this category. Projects are not limited to a specific research or practice area. Students may submit Research-In-Progress abstracts. However, you must be able to present results during the poster session at the Annual Conference. Case Reports are accepted within the Student category. Only completed abstracts will be published in the Journal of Pediatric Pharmacology and Therapeutics.

​Please use the section headings found within the Scientific/Research Abstract or Case Reports section (above).

Student Investigator Award
PPAG Student Investigator Award is available to primary investigators who are currently enrolled in a BSPharm or PharmD program. This award will be granted to the investigator based on their written abstract and the quality of their presentation at the Meeting. In order to be considered for the award, abstracts must be submitted under the "student" category.


Residency Project Presentation Abstracts (Oral Presentation Only. Results are not required)

The Bruce Parks Memorial Pediatric Pharmacy Residency Presentation Showcase was established in 2006. Since its inception, the program has grown from 12 participants to over 100 participants in 2016. The Showcase seeks to stimulate interest in the field of pediatric pharmacy by offering an opportunity to present residency projects at the PPAG Annual Conference each year.

  1. Presentations will be 15 minutes in total length (including question and answer session).
  2. ​Please use section headings for scientific abstracts: Introduction, Methods, Results, Conclusion
  3. You do not need results to submit an abstract in the category.
  4. Deadline for submitting your abstract: March 1, 2017.
  5. Deadline for submitting preferred presentations date (May 4 or May 6) to Jennifer Chow at jennifer.chow@ppag.org: March 1, 2017
  6. Deadline for submitting presentation slides and learning objectives: April 8, 2017
  7. This year's Showcase will take place on May 4 and 6, 2017 at the Charlotte Marriott City Center in Charlotte, NC


While everyone who submits an abstract will be able to present during the Showcase, presentation slots are available on a "first-submit, first-serve" basis. Although you will be able to indicate your preference, it is not guaranteed. Please email your preferred presentation date to Jennifer Chow. You will be informed of your speaking time by Mid-March so you should be able to plan accordingly.

Please note: Residency Project Abstracts are not eligible for Poster Presentation. Residents are welcome to submit a poster abstract for another project or case. If submitting under the Practice or Research categories, results are required.


Thank you

Thank you for submitting your abstract for consideration. Once review is complete, you will receive notification whether or not your poster is accepted for presentation at the meeting.

Thank you and good luck!

Calendar of Events

Conferences and Meetings

Annual Meeting- May 2017